Randomized, Open label, Parallel-group Study Comparing the Pharmacokinetics and Immunogenicity of Alternating Use of SAR341402 and NovoLog? versus Continuous Use of NovoLog in Participants with Type 1 Diabetes Mellitus also Using Insulin Glargine
Details
Age
Adult
Type of Study
Treatment
Locations
Barbara Davis Center
UCD Barbara Davis Center
Principal Investigator
Viralkumar Shah, MD
Study ID
Protocol Number: 19-0250
Is this Study for You?
Not finding the right Study for you? Join ResearchMatch, a nation-wide registry connecting volunteers and researchers